Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR3 | O14843 | 1/20 | 0.47 |
| ▸ | LCK | P06239 | 1/20 | 0.47 |
| ▸ | FYN | P06241 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.43 |
| ▸ | GABRP | O00591 | 4/20 | 0.38 |
| ▸ | GABRD | O14764 | 4/20 | 0.38 |
| ▸ | GABRA1 | P14867 | 4/20 | 0.38 |
| ▸ | GABRB1 | P18505 | 4/20 | 0.38 |
| ▸ | GABRG2 | P18507 | 4/20 | 0.38 |
| ▸ | GABRB3 | P28472 | 4/20 | 0.38 |
| ▸ | GABRA5 | P31644 | 4/20 | 0.38 |
| ▸ | GABRA3 | P34903 | 4/20 | 0.38 |
| ▸ | GABRA2 | P47869 | 4/20 | 0.38 |
| ▸ | GABRB2 | P47870 | 4/20 | 0.38 |
| ▸ | GABRA4 | P48169 | 4/20 | 0.38 |
| ▸ | GABRE | P78334 | 4/20 | 0.38 |
| ▸ | GABRA6 | Q16445 | 4/20 | 0.38 |
| ▸ | GABRG1 | Q8N1C3 | 4/20 | 0.38 |
| ▸ | GABRG3 | Q99928 | 4/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL8679160 | 0.87 | FFAR3 (0.47) | FFAR3LCKFYNTP53SLC7A5 | |
| Acetic Acid SCHEMBL1565106 | 0.86 | — | — | |
| Acetic Acid SCHEMBL4292108 | 0.86 | FFAR3 (0.54) | FFAR3LCKFYNTP53SLC7A5 | |
| Acetic Acid SCHEMBL10591883 | 0.83 | SLC7A5 (0.53) | FFAR3LCKFYNTP53SLC7A5 | |
| Acetic Acid SCHEMBL6425236 | 0.83 | FFAR3 (0.50) | FFAR3LCKFYNTP53SLC7A5 | |
| Acetic Acid SCHEMBL44094 | 0.82 | — | — | |
| Acetic Acid SCHEMBL9151775 | 0.82 | FFAR3 (0.58) | FFAR3LCKFYNTP53SLC7A5 | |
| Acetic Acid SCHEMBL27717337 | 0.82 | FFAR3 (0.58) | FFAR3LCKFYNTP53SLC7A5 | |
| Acetic Acid SCHEMBL670655 | 0.82 | FFAR3 (0.58) | FFAR3LCKFYNTP53SLC7A5 | |
| Acetic Acid SCHEMBL24229 | 0.82 | FFAR3 (0.58) | FFAR3LCKFYNTP53LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1906950-A4 | ANSAMYCIN FORMULATIONS AND METHODS OF USE THEREOF | INFINITY DISCOVERY INC (US) | 2008-09-24 | — | — | EP | claimed |
| EP-1906950-A2 | ANSAMYCIN FORMULATIONS AND METHODS OF USE THEREOF | Infinity Discovery, Inc. (US) | 2008-04-09 | — | — | EP | claimed |
| WO-2007002093-A2 | ANSAMYCIN FORMULATIONS AND METHODS OF USE THEREOF | INFINITY DISCOVERY, INC. (US) | 2007-01-04 | — | — | WO | claimed |
| CN-101472967-B | Method for producing stabilized polyacetal resin, composition, and molded article | POLYPLASTICS CO | 2012-07-11 | — | — | CN | disclosed |
| CN-101472967-A | Method for producing stabilized polyacetal resin, composition, and molded article | POLYPLASTICS CO (JP) | 2009-07-01 | — | — | CN | disclosed |
| EP-1906950-A4 | ANSAMYCIN FORMULATIONS AND METHODS OF USE THEREOF | INFINITY DISCOVERY INC (US) | 2008-09-24 | — | — | EP | disclosed |
| EP-1906950-A2 | ANSAMYCIN FORMULATIONS AND METHODS OF USE THEREOF | Infinity Discovery, Inc. (US) | 2008-04-09 | — | — | EP | disclosed |
| WO-2007002093-A2 | ANSAMYCIN FORMULATIONS AND METHODS OF USE THEREOF | INFINITY DISCOVERY, INC. (US) | 2007-01-04 | — | — | WO | disclosed |
| EP-0772799-B1 | PHOTOGRAPHIC DEVELOPING COMPOSITION AND ITS APPLICATION | KODAK POLYCHROME GRAPHICS CO (US) | 2001-10-17 | — | — | EP | disclosed |
| US-5792598-A | DEVELOPING AND FIXING, DEVELOPING AGENT IS FREE OF DIHYDROXYBENZENE AND COMPRISES ASCORBIC ACID OR SALTS OR DERIVATIVES, ALKALI METAL SULFITE AND CARBONATE BUFFER; NONTOXIC | INTERNATIONAL PAPER COMPANY (US) | 1998-08-11 | — | — | US | disclosed |
| EP-0772799-A4 | — | — | 1997-06-18 | — | — | EP | disclosed |
| EP-0772799-A1 | PHOTOGRAPHIC DEVELOPING COMPOSITION AND ITS APPLICATION | INTERNATIONAL PAPER COMPANY (US) | 1997-05-14 | — | — | EP | disclosed |
| US-5503966-A | CONTAINING ASCORBIC ACID BASED DEVELOPER, SULFITE, POTASSIUM CARBONATE BUFFER; FREE OF DIHYDROXYBENZENE DEVELOPERS | INTERNATIONAL PAPER COMPANY (US) | 1996-04-02 | — | — | US | disclosed |
| WO-1996003677-A1 | PHOTOGRAPHIC DEVELOPING COMPOSITION AND ITS APPLICATION | INTERNATIONAL PAPER COMPANY (US) | 1996-02-08 | — | — | WO | disclosed |
| EP-0133182-A1 | OXIDATION-REDUCTION COLOR PRODUCTION-TYPE HEAT-SENSITIVE RECORDING UNIT | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1985-02-20 | — | — | EP | disclosed |
| US-4404187-A | RESISTANCE TO HEATING | BEHRINGWERKE AKTIENGESELLSCHAFT (DE) | 1983-09-13 | — | — | US | disclosed |